Pharma Journalist - Page 63 of 956 -

Sanofi, Regeneron Expand Antibody Collaboration With $8B Deal

Abogen, Novartis Sign $7.2B RNA Therapeutics Deal

CAS, Novartis Partner on AI-Ready Reaction Data for Drug Discovery

EC Approves First Simponi Biosimilar Gobivaz in Europe

FDA Approves Arrowhead’s REDEMPLO, the First siRNA Therapy for Familial Chylomicronemia Syndrome

EU Approves First Subcutaneous Version of Keytruda for All Adult Indications

LNP Innovation Surges as 5th LNP Summit Unveils 2026 Agenda

EU Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis

FDA Approves AbbVie’s EPKINLY Combination for Relapsed or Refractory Follicular Lymphoma

Genprex Secures U.S. Patent Protecting REQORSA and PD-L1 Antibody Combination

J&J to Acquire Halda Therapeutics in $3.05B Cancer Therapy Deal

EMA Panel Backs High-Dose SPINRAZA Regimen for Spinal Muscular Atrophy

Johnson & Johnson to Acquire Halda Therapeutics for $3.05B to Expand Oncology Pipeline